IGF2 promotes growth of adrenocortical carcinoma cells, but its overexpression does not modify phenotypic and molecular features of adrenocortical carcinoma.
Insulin-like growth factor 2 (IGF2) overexpression is an important molecular marker of adrenocortical carcinoma (ACC), which is a rare but devastating endocrine cancer. It is not clear whether IGF2 overexpression modifies the biology and growth of this cancer, thus more studies are required before I...
Guardado en:
Autores principales: | Marine Guillaud-Bataille, Bruno Ragazzon, Aurélien de Reyniès, Claire Chevalier, Isabelle Francillard, Olivia Barreau, Virginie Steunou, Johann Guillemot, Frédérique Tissier, Marthe Rizk-Rabin, Fernande René-Corail, Abir Al Ghuzlan, Guillaume Assié, Xavier Bertagna, Eric Baudin, Yves Le Bouc, Jérôme Bertherat, Eric Clauser |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d93b7d6056db476b9f50e1676676fe75 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Silencing mutated β-catenin inhibits cell proliferation and stimulates apoptosis in the adrenocortical cancer cell line H295R.
por: Sébastien Gaujoux, et al.
Publicado: (2013) -
Adrenocortical Carcinoma in Childhood: A Systematic Review
por: Maria Riedmeier, et al.
Publicado: (2021) -
Consensus on the Treatment of Adrenocortical Carcinoma with Mitotane(2021)
por: Multi-disciplinary Team for Rare Diseases, Peking Union Medical College Hospital
Publicado: (2021) -
Adrenocortical Carcinoma Discovered with Point-of-care Ultrasound
por: Mark McIntyre, et al.
Publicado: (2021) -
Carcinoma adrenocortical virilizante: tratamiento quirúrgico y quimioterapia
por: Vargas P,Lautaro, et al.
Publicado: (1993)